A Blog by AMCP CEO Susan Cantrell


AMCP_Beyond 
 

 


‘Ripped from the Headlines’ – Annual Meeting Sessions Tackle Real-Life Issues

 

March 1, 2017 

Every morning — like many of you — I settle behind my desk, take a sip of coffee and read the AMCP Daily Dose. This publication, full of valuable news and information, frequently highlights issues and individuals we’re featuring at our Annual Meeting, March 27-30, in Denver. Several caught my eye recently.

The Boston Globe last week reported on two Harvard Pilgrim pay-for-performance programs focused on rheumatoid arthritis and osteoporosis aligned with adherence and effectiveness measures. The strategy is designed to curb spending while giving patients access to costly treatments.

We’re delighted to have the primary architect of that program presenting in Denver. Jim Kenney, Manager of Specialty and Pharmacy Contracts at Harvard Pilgrim, will lead a session appropriately titled “Approaches to Managed Care Contracting with Pharmaceutical Manufacturers.” This encore session will discuss innovations in managed care pharmacy contracting, including indication-based contracts and price protection arrangements. You won’t want to miss this one.

Another recent article in Healthcare Risk Management Review described the launch of an Enhanced Medication Therapy Management (MTM) program by Tabula Rasa HealthCare. This pilot program of the Part D Enhanced MTM Model involves seven states: Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota and Wyoming. Among other things, the story explains requirements of the Centers for Medicare and Medicaid Innovation (CMMI), which oversees the model.

Again, we’re delighted to have an architect of this program at our meeting. Nicholas Minter is Health Insurance Specialist at CMMI and lead of the Part D Enhanced MTM Model. His session is aptly titled “The CMMI Perspective on the Enhanced MTM Model: A Look at Today and Tomorrow.” Nicholas will explain the preliminary impact of the model on managed care pharmacy stakeholders, MTM providers, and other pharmacies and pharmacists.

Finally, as you know, one can barely turn on the television — let alone open the Daily Dose — without reading or hearing about Congress’s plans to repeal and replace the Affordable Care Act (ACA). The New York Times recently reported that repeal is facing obstacles in the House and Senate. How this all plays out, and what it means to the health care marketplace, is a topic on the minds of many AMCP members.

Once again, we are fortunate to have two leading experts who will give us a glimpse into some possible scenarios. Kevin Grabenstatter and Todd Clark, both Managing Directors at the global management company L.E.K. Consulting, will present “What Lies Ahead for the Business of US Health Care?” They will identify the market forces most likely to shape the health care system and explain how these forces may affect managed care organizations and other key industry stakeholders.

This is just a taste of what we’re seeing in the news and what you will experience first-hand when you attend the AMCP Annual Meeting in Denver, March 27-30. See you there.


Susan A. Cantrell, RPh, CAE is CEO of the Academy of Managed Care Pharmacy 


 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 

February 1, 2017 

Sometimes the best laid plans are upended when you least expect it!

In mid-January, the FDA released draft guidance to facilitate the sharing of information between biopharmaceutical companies and population health decision makers. To say we were pleasantly surprised is an understatement. ... Read more 


 


Making PIE to Better Serve Patients

 

January 11, 2017 

Let’s imagine you’re a big city mayor and it’s time to order a new fleet of police cars for next year. Applying due diligence, you set out to compare various models from a variety of manufacturers. ... Read more 


 


Century Cures Act Advances AMCP's FDAMA Goals, Improves Value-Based Communications Between Manufacturers and Managed Care Pharmacy

 

December 22, 2016 

Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress, followed by President Obama’s prompt signature. ... Read more 


 


Pharmacy Profession Comes Together to Help Document and Improve Patient Outcomes Through Medication Therapy Management

 

November 7, 2016 

People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for medication therapy management (MTM) services. ... Read more 


 


AMCP really knows how to get things done!

 

October 13, 2016 

Not long ago a respected individual in the health care arena told one of my senior staff: “Compared to other associations I work with, AMCP really knows how to get things done.” You cannot imagine how proud I felt ... Read more 


 


AMCP Volunteers Are a Happy Lot

 

September 20, 2016 

There are many ways to measure the health and vitality of a professional association. The most crucial indicators, I’ve found, center on the engagement of an organization’s volunteers. This can be measured in the number of volunteer opportunities provided, the number of members who sign up, and the level of satisfaction they get from volunteering. ... Read more 


 


The Post Cites Pharmacists’ Expanding Role on Medical Teams

 

August 26, 2016 

Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15). I couldn’t read it fast enough and encourage members to do likewise, as it highlights two of the most important developments in health care. ... Read more 


 


Seizing Opportunity: AMCP Nexus 2016 Offers Knowledge, Advancement and More

 

August 3, 2016 

“Healing is a matter of time, but it is sometimes also a matter of opportunity,” said the great Hippocrates, father of western medicine.

Opportunity, in fact, is a crucial element in the work that managed care pharmacy professionals engage in every day to improve the health, wellbeing and “healing” of millions of patients. We seize opportunities to find the right medicines for the right patients at the right time. ... Read more 


 


BRC Now Lets You Look It Up

 

July 13, 2016 

It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.” At the time some still called them “follow-on” biopharmaceutics. ... Read more 


 


Is FDAMA Section 114 Finally Ready for Prime Time?

 

June 24, 2016 

Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.

Our profession operates best when we have broad access to the latest evidence-based data on the multitude of products coming to market today. We can plan, we can assess. With this information, managed care pharmacy professionals can help health care providers and patients select the right drug for the right patient at the right time, while making appropriate use of our scarce health care dollars. ... Read more 


 


Getting it straight with the updated AMCP Format!

 

May 19, 2016 

Using the best evidence possible to make informed health care decisions is a hallmark of managed care pharmacy. But making sense of the data often is no easy task, especially when it comes to analyzing pharmaceuticals and the value they bring to patients and the health care system... Read more 


 


CEO Susan Cantrell Addresses AMCP Annual Meeting

 

May 10, 2016 

New&Views announces a new monthly column by CEO Susan A. Cantrell, RPh, CAE, on breaking news and critical issues. Her first column presents her recent address―her first to the membership―at AMCP’s recent Annual Meeting.

“It is truly an honor to be standing before you today as the Academy’s new CEO. While new to the AMCP staff, I’ve been an observer and at times a participant in the terrific work of this organization. ..." Read more.